Status:
COMPLETED
Probiotics in the Treatment of Irritable Bowel Syndrome
Lead Sponsor:
Isfahan University of Medical Sciences
Conditions:
Irritable Bowel Syndrome
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
PHASE3
Brief Summary
Evidence have shown benefits of gut flora modulation in treatment of irritable bowel syndrome (IBS), but few reports are available on the effects of multistrain probiotics and there are few reports av...
Eligibility Criteria
Inclusion
- age between 18 and 65
- diagnosis of IBS based on the Rome III criteria
- willingness to participate
Exclusion
- receiving other probiotics compound during the study
- receiving antibiotics during the study
Key Trial Info
Start Date :
April 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2013
Estimated Enrollment :
132 Patients enrolled
Trial Details
Trial ID
NCT01837472
Start Date
April 1 2012
End Date
April 1 2013
Last Update
April 23 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Gastroenterology, Alzahra Hospital
Isfahan, Isfahan, Iran, 81746-73461